To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer

Clinical trial NCT04843319 · TERMINATED

Trial details

NCT number: NCT04843319
Sponsor: Veru Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Prostate Adenocarcinoma

Start date: 2021-06-09
Primary completion: 2023-01-19
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.